Prostate biopsy in selecting candidates for hemiablative focal therapy.
Repository Usage Stats
Focal therapy (FT) for the management of clinically localized prostate cancer (PCa) is growing from a concept to reality because of increased interest of both patients and physicians. Selection protocols, however, are yet to be established. We discuss the role of prostate biopsy in candidate selection for FT and highlight the different strategies and technical aspects of the use of prostate biopsy in this setting. In our opinion, prostate biopsy plays a major role in the selection process and tailoring appropriate treatment strategy to the patient. FT necessitates dedicated biopsy schemes that would reliably predict the extent, nature, and location of PCa in selected patients. Currently, there is insufficient scientific evidence to propose a specific biopsy scheme that could fit every candidate, providing accurate characterization of the disease in the individual patient. Further research is necessary to establish solid selection protocols that would reliably identify appropriate candidates for FT of PCa.
Published Version (Please cite this version)10.1089/end.2009.0473
Publication InfoHruza, M; Mouraviev, V; Polascik, Thomas J; Rassweiler, J; & Tsivian, M (2010). Prostate biopsy in selecting candidates for hemiablative focal therapy. J Endourol, 24(5). pp. 849-853. 10.1089/end.2009.0473. Retrieved from https://hdl.handle.net/10161/3314.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
More InfoShow full item record
Professor of Surgery
Prostate cancer imaging Focal therapy of prostate cancer Prostate cancer outcomes Kidney cancer outcomes Minimally invasive surgery Nerve sparing cryotherapy
Alphabetical list of authors with Scholars@Duke profiles.